Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ischemic Heart Disease
  Free Subscription

Articles published in
Eur Heart J
    November 2026
  1. WENZL FA, Schweiger V, Smolle MA, Zech D, et al
    Takotsubo syndrome diagnosis: the biomarker-based BioTAK score.
    Eur Heart J. 2026;47:6166-6179.
    >> Share

  2. PICOD A, Price S, Hanff T
    Renin-angiotensin-aldosterone system failure drives inappropriate vasodilation in cardiogenic shock: a hypothesis.
    Eur Heart J. 2026;47:6161-6165.
    >> Share

    October 2026
  3. QIN J, Chen T, Qu L
    Coronary micro- and nanoplastics in ST-segment elevation myocardial infarction: antecedent exposure or post-thrombotic enrichment?
    Eur Heart J. 2026 Oct 27:ehag800. doi: 10.1093.
    >> Share

  4. CREA F
    Fifth Universal Definition of Myocardial Infarction and an update on lipoprotein(a) and inflammation.
    Eur Heart J. 2026;47:5893-5898.
    >> Share

  5. JUKEMA JW, Van Neer NJ, Szarek M, Cobbaert C, et al
    Interleukin-6 and C-reactive protein prognostic value following acute coronary syndrome.
    Eur Heart J. 2026;47:6008-6017.
    >> Share

  6. KATAOKA Y, Ray KK, Nicholls SJ, Katasako-Yabumoto A, et al
    Lipoprotein(a) and residual cardiovascular risks in Japanese patients with coronary artery disease who achieve guideline-recommended low-density lipoprotein cholesterol goals.
    Eur Heart J. 2026;47:5991-6003.
    >> Share

  7. PAOLISSO P, Scisciola L, Belmonte M, Scarsini R, et al
    Micro- and nano-plastics in the coronary circulation and air pollution exposure in ischaemic heart disease presentation.
    Eur Heart J. 2026;47:5860-5876.
    >> Share


  8. Correction: Fifth Universal Definition of Myocardial Infarction (2026): On behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the U
    Eur Heart J. 2026 Oct 21:ehag811. doi: 10.1093.
    >> Share

  9. GALLI M, Ten Berg J, Berry C
    Meta-analyses limitations and the compelling case for a contemporary, pragmatic trial of clopidogrel vs aspirin for secondary prevention of coronary heart disease: clopidogrel is not superior to aspirin in non-East Asian patients.
    Eur Heart J. 2026 Oct 10:ehag805. doi: 10.1093.
    >> Share

  10. MAHENDIRAN T, Corradetti S, Perera D, Pijls NHJ, et al
    Coronary autoregulation: the complex interplay between epicardial and microvascular resistance.
    Eur Heart J. 2026;47:5279-5292.
    >> Share

    September 2026
  11. ARMSTRONG PW, Danays T, Westerhout CM
    Intracranial haemorrhage following tenecteplase fibrinolysis for acute myocardial infarction.
    Eur Heart J. 2026 Sep 21:ehag754. doi: 10.1093.
    >> Share

  12. LI S, Wang W, Zhou H, Zhang Y, et al
    Tropical cyclones and acute coronary syndromes: a Chinese nationwide study.
    Eur Heart J. 2026;47:4826-4838.
    >> Share

  13. MAY HT, Le VT, Anderson JL, Iverson L, et al
    Targeted vitamin D supplementation and major adverse cardiovascular events after myocardial infarction: the TARGET-D trial.
    Eur Heart J. 2026 Sep 7:ehag611. doi: 10.1093.
    >> Share

  14. DAVIS JW, Manson JE
    More is not always better: vitamin D supplementation post-myocardial infarction in the Target-D trial.
    Eur Heart J. 2026 Sep 7:ehag672. doi: 10.1093.
    >> Share

    August 2026
  15. VORA KP, Bhatt K, Doshi S, Poptani V, et al
    Intravenous dexrazoxane for haemorrhagic myocardial infarction: the SHIELD-MI study.
    Eur Heart J. 2026 Aug 31:ehag715. doi: 10.1093.
    >> Share

  16. TARANTINI G, Zhang X, Nai Fovino L, Kan J, et al
    One vs twelve month aspirin after percutaneous coronary intervention for acute myocardial infarction: individual patient-data analysis of TARGET-FIRST and ULTIMATE-DAPT trials.
    Eur Heart J. 2026 Aug 29:ehag737. doi: 10.1093.
    >> Share

  17. WOOD DA, Jennings CS, Kotseva K, Adamska A, et al
    ESC Guidelines on prevention and rehabilitation in coronary heart disease and current practice: the EUROASPIRE VI survey.
    Eur Heart J. 2026 Aug 29:ehag741. doi: 10.1093.
    >> Share

  18. SEPEHRI SHAMLOO A, Chiba T, Tijssen JGP, Althof T, et al
    Mortality reduction with implanted defibrillator for primary prevention of sudden death after Myocardial Infarction: temporal trends in the PROFID study.
    Eur Heart J. 2026 Aug 28:ehag706. doi: 10.1093.
    >> Share

  19. DE FERRARI GM, Giugliano RP, Leiter LA, Nicolau JC, et al
    Evolocumab and risk of first myocardial infarction: the VESALIUS-CV trial.
    Eur Heart J. 2026 Aug 28:ehag739. doi: 10.1093.
    >> Share

  20. MILLS NL, Newby LK, Zaman S, Almahmeed WA, et al
    Fifth Universal Definition of Myocardial Infarction (2026).
    Eur Heart J. 2026 Aug 28:ehag101. doi: 10.1093.
    >> Share

  21. BAI B, Cao L, Lin K, Luo C, et al
    Aerobic exercise attenuates peri-infarct fibrosis and improves fitness early after acute myocardial infarction: a randomized trial.
    Eur Heart J. 2026 Aug 26:ehag651. doi: 10.1093.
    >> Share

  22. HEUSCH G, Kleinbongard P, Gourine AV
    The vagus nerve in myocardial infarction.
    Eur Heart J. 2026 Aug 26:ehag674. doi: 10.1093.
    >> Share

  23. NAIR A, van der Kaaij NP, Kluin J, Rogers J, et al
    Total artificial hearts: an evolution on the horizon.
    Eur Heart J. 2026;47:4396-4409.
    >> Share

  24. MCCARTHY CP, Whelton H, McEvoy JW
    Periodontitis and coronary heart disease: inflamed gums, diseased arteries?
    Eur Heart J. 2026 Aug 21:ehag634. doi: 10.1093.
    >> Share

  25. PARGAONKAR VS, Schnittger I, Wong CCY, Wang H, et al
    Angina with non-obstructive coronary arteries and myocardial bridge: long-term outcomes of surgical unroofing.
    Eur Heart J. 2026;47:4290-4303.
    >> Share

  26. LARSEN AF, Kuhl JT, Sigvardsen PE, Afzal S, et al
    Gender-related risk of myocardial infarction and subclinical coronary atherosclerosis: a Danish population cohort study.
    Eur Heart J. 2026 Aug 12:ehag612. doi: 10.1093.
    >> Share

    July 2026
  27. PARKER SJ, Mao C, Caudell DL, Seals AL, et al
    Molecular mechanism leading to human coronary atherosclerosis assessed by proteomic analysis and RNA sequences.
    Eur Heart J. 2026;47:3840-3856.
    >> Share

  28. RAVEENDRA K, Gale CP
    Translating evidence of beta-blocker effectiveness following myocardial infarction.
    Eur Heart J. 2026 Jul 17:ehag506. doi: 10.1093.
    >> Share

    June 2026
  29. KANG J, Han M, Wang L
    Fulminant myocarditis complicated by acute myocardial infarction.
    Eur Heart J. 2026 Jun 23:ehag366. doi: 10.1093.
    >> Share

  30. PUELACHER C, Glarner N, Mueller C
    Despite uncertainty, cardiologist involvement in care of perioperative myocardial infarction/injury appears reasonable.
    Eur Heart J. 2026 Jun 19:ehag475. doi: 10.1093.
    >> Share

  31. GOVIND A
    Peri-operative myocardial infarction after non-cardiac surgery: validating the case for cardiologist involvement while acknowledging what remains unresolved.
    Eur Heart J. 2026 Jun 19:ehag473. doi: 10.1093.
    >> Share

  32. CREA F
    Ischaemic heart disease: focus on sex and gender differences, coronary pathophysiology, and remodelling after myocardial infarction.
    Eur Heart J. 2026;47:2711-2717.
    >> Share

  33. KAKIZAKI R, Biccire FG, Losdat S, Ueki Y, et al
    Silent plaque ruptures in non-obstructive lesions of non-infarct-related arteries: a multimodality, serial intracoronary imaging study.
    Eur Heart J. 2026;47:2814-2826.
    >> Share

  34. MANFRINI O, Tousoulis D, Antoniades C, Badimon L, et al
    Sex and gender differences in coronary pathophysiology and ischaemic heart disease.
    Eur Heart J. 2026;47:2727-2749.
    >> Share

  35. WEBB CM, Collins P
    Stable angina in young women.
    Eur Heart J. 2026;47:2766-2776.
    >> Share

  36. ANDREOTTI F, Thiele H, Vrints C, Jobs A, et al
    Great debate: the new risk factor-weighted clinical likelihood model is useful to estimate the initial pre-test probability of obstructive coronary artery disease in individuals with suspected chronic coronary syndromes.
    Eur Heart J. 2026;47:2777-2792.
    >> Share

  37. EIJSVOGELS TMH, Kim JH, Aengevaeren VL, D'Ascenzi F, et al
    Masters athletes with abnormal cardiovascular findings: a clinical consensus statement of the European Association of Preventive Cardiology of the ESC and the American College of Cardiology.
    Eur Heart J. 2026;47:2541-2560.
    >> Share

    May 2026
  38. CENKO E, Badimon L, Vadala G, Merkus D, et al
    Pathophysiology, prevention, and management of coronary microvascular obstruction.
    Eur Heart J. 2026 May 26:ehag334. doi: 10.1093.
    >> Share

  39. KRISTENSEN AMD, Jortveit J, Holmager T, Atar D, et al
    Outcomes in the BETAMI-DANBLOCK trial compared with a Norwegian nationwide myocardial infarction population.
    Eur Heart J. 2026 May 25:ehag348. doi: 10.1093.
    >> Share

  40. JOHNSON TW, Gonzalo N, de la Torre Hernandez JM, Amabile N, et al
    Intracoronary imaging for left main percutaneous coronary intervention: a clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the European Bifurcation Club (EBC).
    Eur Heart J. 2026 May 15:ehag353. doi: 10.1093.
    >> Share

  41. LORUSSO R, Matteucci M, Ronco D, Massimi G, et al
    Ventricular free-wall rupture, ventricular pseudoaneurysm, and papillary muscle rupture complicating acute myocardial infarction.
    Eur Heart J. 2026 May 11:ehag164. doi: 10.1093.
    >> Share

  42. HOLMGREN L, von Koch S, Andell P, Sorensson P, et al
    Outcomes after a first acute myocardial infarction in patients with or without congenital heart disease.
    Eur Heart J. 2026 May 11:ehag216. doi: 10.1093.
    >> Share

  43. TEPPO K, Airaksinen KEJ, Wittfooth S
    Long cardiac troponin T in myocardial infarction: the SuperTROPO study is a promising starting point.
    Eur Heart J. 2026 May 7:ehag332. doi: 10.1093.
    >> Share

  44. MENG C, Wang Y, Miao G
    Long cardiac troponin T in myocardial infarction: a promising diagnostic tool, a precision imperative.
    Eur Heart J. 2026 May 7:ehag327. doi: 10.1093.
    >> Share

  45. CORTESE B, Mehilli J, Belmonte M, Wanha W, et al
    Great debate: drug-coated balloons are preferable to drug-eluting stents for coronary in-stent restenosis.
    Eur Heart J. 2026;47:2035-2043.
    >> Share

  46. ALEXANDROU M, Sandoval Y, Alfonso F, Brilakis ES, et al
    Subacute coronary artery occlusion: complexities of the grey zone.
    Eur Heart J. 2026;47:2022-2034.
    >> Share

  47. AZARBARZIN A, Vena D, Esmaeili N, Wellman A, et al
    Cardiovascular benefit of continuous positive airway pressure according to high-risk obstructive sleep apnoea: a multi-trial analysis.
    Eur Heart J. 2026;47:2077-2089.
    >> Share

    April 2026
  48. KRONBORG AH, Hasselbalch RB, Pedersen CHG, Knudsen SS, et al
    Macrotroponin I: association with suspected myocardial infarction with non-obstructive coronary artery.
    Eur Heart J. 2026 Apr 28:ehag312. doi: 10.1093.
    >> Share

  49. NURMOHAMED NS, Bhatt DL
    Bridging the gap in prevention of first myocardial infarction.
    Eur Heart J. 2026 Apr 24:ehag284. doi: 10.1093.
    >> Share

  50. SIMEON MJ
    Gaps in cardiovascular risk identification and preventive therapy before first myocardial infarction.
    Eur Heart J. 2026 Apr 24:ehag283. doi: 10.1093.
    >> Share

  51. ALCOVER S, Ramos-Regalado L, Munoz-Garcia N, Giron GO, et al
    Eicosapentaenoic acid ethyl ester, cardiac metabolomic and lipidomic signatures, and cardioprotection in myocardial infarction.
    Eur Heart J. 2026 Apr 17:ehag187. doi: 10.1093.
    >> Share

  52. BHATT DL, Perrone Filardi P, Khan I, Tunon J, et al
    PCSK9 inhibitor treatment and outcomes in patients with atherosclerotic cardiovascular disease but without prior ischaemic events: an observational study.
    Eur Heart J. 2026 Apr 16:ehag176. doi: 10.1093.
    >> Share

  53. OTERO S, Radike M, Ben-Aicha S, Mendieta G, et al
    Cardioprotection with intravenous statin administration during myocardial infarction vs. oral preloading: a preclinical study.
    Eur Heart J. 2026 Apr 15:ehag269. doi: 10.1093.
    >> Share

  54. GUIDA G, Disabato G, Piepoli M
    A natural experiment in the air: particulate matter and acute myocardial infarction subtypes during the COVID-19 pandemic.
    Eur Heart J. 2026 Apr 9:ehag218. doi: 10.1093.
    >> Share

  55. ROSSELLO X
    Age, frailty, and outcomes in myocardial infarction: a new paradigm for an old concept.
    Eur Heart J. 2026 Apr 9:ehag213. doi: 10.1093.
    >> Share

    March 2026
  56. NYEN JE, Kristensen AMD, Dammen T, Zwisler AD, et al
    Beta-blockers, depression, and anxiety after myocardial infarction: the BETAMI-DANBLOCK trial.
    Eur Heart J. 2026 Mar 25:ehag200. doi: 10.1093.
    >> Share

  57. QI Y, Li J, Yang Z, Liu J, et al
    Cardiovascular disease in China: epidemiological evolution and implications.
    Eur Heart J. 2026 Mar 25:ehaf1121. doi: 10.1093/eurheartj/ehaf1121.
    >> Share

  58. METEVA D, Pedicino D, Abdelwahed YS, Krankel N, et al
    Acute coronary syndrome with plaque erosion: clinical characteristics, mechanisms, and unmet needs.
    Eur Heart J. 2026;47:1403-1414.
    >> Share

  59. SEKIMOTO T, Grogan A, Kawakami R, Shiraki T, et al
    Plaque fissure and calcified nodule: histopathological findings.
    Eur Heart J. 2026;47:1415-1426.
    >> Share


  60. Correction to: Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts.
    Eur Heart J. 2026 Mar 12:ehag167. doi: 10.1093.
    >> Share

  61. MA M, Zhang Y, Gao L, Wang Z, et al
    Atherosclerotic progression at sites of low shear stress is attenuated by myeloid-PlexinD1 deficiency through suppression of classical macrophage polarization.
    Eur Heart J. 2026;47:1242-1259.
    >> Share

  62. PARK DW, Boden WE, De Caterina R, Gallinoro E, et al
    Great debate: preventive percutaneous coronary intervention added to optimal medical treatment should be the default treatment for non-flow-limiting vulnerable plaques.
    Eur Heart J. 2026 Mar 6:ehag103. doi: 10.1093.
    >> Share

    February 2026
  63. PEDICINO D, Liuzzo G
    Weekly Journal Scan: What should we CELEBRATE and what remains uncertain about early platelet inhibition in ST-elevation myocardial infarction.
    Eur Heart J. 2026 Feb 28:ehag125. doi: 10.1093.
    >> Share

  64. ZARAGOZA C
    When RNAs come full circle: new regulators of healing after myocardial infarction.
    Eur Heart J. 2026 Feb 18:ehag038. doi: 10.1093.
    >> Share

  65. ISHII M, Nakamura T, Ikebe S, Otsuka Y, et al
    Air pollution before and during the COVID-19 pandemic: changes in risk of acute myocardial infarction.
    Eur Heart J. 2026 Feb 13:ehag102. doi: 10.1093.
    >> Share

  66. JUNG M, Schmidt A, Sansonetti M, Al Soodi B, et al
    Macrophage-specific circular RNA circHIPK2, inflammation, and fibrosis after myocardial infarction.
    Eur Heart J. 2026 Feb 11:ehaf1116. doi: 10.1093/eurheartj/ehaf1116.
    >> Share

  67. LEE SJ, Lee SJ, Hong SJ, Cho DK, et al
    Optical coherence tomography-guided stent optimization for complex coronary lesions: the OCCUPI trial.
    Eur Heart J. 2026;47:608-621.
    >> Share

  68. MINER S, Mejia-Renteria H, Leone AM, Velollari O, et al
    Endotypes of angina with non-obstructive coronary arteries: a prospective multicentre study.
    Eur Heart J. 2026;47:594-604.
    >> Share

    January 2026
  69. WEINTRAUB WS, Boden WE
    Does post-surgery cardiology evaluation improve clinical outcome in patients with a peri-operative myocardial infarction?
    Eur Heart J. 2026 Jan 30:ehaf1073. doi: 10.1093/eurheartj/ehaf1073.
    >> Share

  70. GLARNER N, Puelacher C, Gualandro DM, Pargger M, et al
    Peri-operative myocardial infarction/injury after non-cardiac surgery: association between cardiologist evaluation and outcomes.
    Eur Heart J. 2026 Jan 30:ehaf846. doi: 10.1093.
    >> Share

  71. VERGALLO R, Pedicino D
    Weekly Journal Scan: Complete revascularization in acute myocardial infarction improves major cardiovascular outcomes.
    Eur Heart J. 2026 Jan 30:ehag027. doi: 10.1093.
    >> Share

  72. TEPPO K, Airaksinen KEJ, Vasankari T, Linko-Parvinen A, et al
    Long forms of cardiac troponin T for myocardial infarction diagnosis: the SuperTROPO study.
    Eur Heart J. 2026;47:490-499.
    >> Share

  73. SAVONITTO S, Alpert JS, Thiele H, Campo G, et al
    Non-ST-segment elevation acute coronary syndrome: understanding the full spectrum to guide management.
    Eur Heart J. 2026;47:423-437.
    >> Share

  74. VON SCHEIDT M, Adkar SS, Krefting J, Hoermann G, et al
    Clonal haematopoiesis of indeterminate potential and mortality in coronary artery disease.
    Eur Heart J. 2026;47:453-469.
    >> Share

  75. REHMAN MB, Bjornson E, Adiels M, Morze J, et al
    Risk-weighted apoB: a novel summary metric outperforming traditional lipid biomarkers in predicting coronary heart disease.
    Eur Heart J. 2026 Jan 22:ehaf1124. doi: 10.1093/eurheartj/ehaf1124.
    >> Share

  76. KIM MC, Ahn JH, Hyun DY, Lim Y, et al
    Complete revascularization timing in ST-segment elevation myocardial infarction and multivessel disease with heart failure: the OPTION-STEMI trial.
    Eur Heart J. 2026 Jan 6:ehaf924. doi: 10.1093.
    >> Share

  77. GVOZDEVA A, Zakiev V, Ushakova O
    The beneficial effect of heart rate-lowering therapy on mortality in post-myocardial infarction patients across the treatment eras.
    Eur Heart J. 2026 Jan 6:ehaf1052. doi: 10.1093/eurheartj/ehaf1052.
    >> Share

  78. SANIDAS E, Michalopoulou H, Thomopoulos C
    Beta-blockers in post-myocardial infarction patients: refractive errors in reading the evidence.
    Eur Heart J. 2026 Jan 6:ehaf1053. doi: 10.1093/eurheartj/ehaf1053.
    >> Share

    December 2025
  79. KRALER S, Liberale L, Tirandi A, Moriero M, et al
    The junctional protein associated with coronary artery disease predicts adverse cardiovascular events in patients with acute coronary syndromes at high residual risk.
    Eur Heart J. 2025 Dec 23:ehaf979. doi: 10.1093.
    >> Share

  80. BERRY C, Stanley B, Duklas P, Layland J, et al
    Fractional flow reserve vs angiography in non-ST- elevation myocardial infarction: long-term results of the FAMOUS-NSTEMI trial.
    Eur Heart J. 2025 Dec 8:ehaf925. doi: 10.1093.
    >> Share

  81. VOLLEBERG RHJA, Luttikholt TJ, van der Waerden RGA, Cancian P, et al
    Artificial intelligence-based identification of thin-cap fibroatheromas and clinical outcomes: the PECTUS-AI study.
    Eur Heart J. 2025;46:5032-5041.
    >> Share

  82. ANDERSEN MH, Jensen JM, Kanstrup H, Sand NPR, et al
    Low-density lipoprotein cholesterol and cardiovascular risk in the absence of calcifications on computed tomography: the Western Denmark Heart Registry.
    Eur Heart J. 2025;46:5062-5072.
    >> Share

  83. KIRMES K, Han J, Klug M, Bloxham CJ, et al
    Reticulated platelets in coronary artery disease: a multidimensional approach unveils prothrombotic signalling and novel therapeutic targets.
    Eur Heart J. 2025;46:4901-4917.
    >> Share

    November 2025
  84. ZHANG L, Zhang YL, Ding D
    Immune checkpoint inhibitor-associated acute myocardial infarction: a case report.
    Eur Heart J. 2025 Nov 28:ehaf987. doi: 10.1093.
    >> Share

  85. MOHIADDIN H, Sze S, Damluji AA, Ladwiniec A, et al
    Frailty and long-term outcomes in younger patients with acute myocardial infarction.
    Eur Heart J. 2025 Nov 25:ehaf876. doi: 10.1093.
    >> Share

  86. AN KR, Vervoort D, Qiu F, Tam DY, et al
    Women with chronic coronary artery disease: long-term outcomes after percutaneous coronary intervention vs coronary artery bypass grafting.
    Eur Heart J. 2025 Nov 25:ehaf806. doi: 10.1093.
    >> Share

  87. SERRUYS PW, Oshima A, Ferraz-Costa G, Garg S, et al
    Coronary revascularization: a long-term perspective.
    Eur Heart J. 2025 Nov 22:ehaf883. doi: 10.1093.
    >> Share

  88. PEDICINO D, Volpe M
    Weekly Journal Scan: Reshaping the boundaries of beta-blocker use after acute myocardial infarction beyond reduced ejection fraction?
    Eur Heart J. 2025 Nov 18:ehaf856. doi: 10.1093.
    >> Share

  89. DUNCKER D, Marijon E, Metra M, Piot O, et al
    Sudden cardiac death in newly diagnosed non-ischaemic or ischaemic cardiomyopathy assessed with a wearable cardioverter-defibrillator: the German nationwide SCD-PROTECT study.
    Eur Heart J. 2025;46:4597-4606.
    >> Share

  90. ZHANG B, Yang J, Ge J
    First myocardial infarction: incorporating non-traditional risk factors to bridge the prevention gap.
    Eur Heart J. 2025 Nov 11:ehaf851. doi: 10.1093.
    >> Share

  91. VERGALLO R, Patrono C
    Weekly Journal Scan: Ischaemic vs bleeding risk early after myocardial infarction-which should we TARGET FIRST?
    Eur Heart J. 2025 Nov 11:ehaf893. doi: 10.1093.
    >> Share

  92. NURMOHAMED NS, Bhatt DL
    Preventing the first myocardial infarction: from reaction to action.
    Eur Heart J. 2025 Nov 11:ehaf852. doi: 10.1093.
    >> Share

  93. BOERHOUT CKM, Namba HF, Liu T, Beijk MAM, et al
    Coronary function testing vs angiography alone to guide treatment of angina with non-obstructive coronary arteries: the ILIAS ANOCA trial.
    Eur Heart J. 2025;46:4396-4406.
    >> Share

  94. VAN ZIJVERDEN LM, Thijs A, van Diemen JJK, Wiepjes CM, et al
    Transgender persons receiving gender-affirming hormone therapy: risk of acute cardiovascular events in a Dutch cohort study.
    Eur Heart J. 2025 Nov 4:ehaf837. doi: 10.1093.
    >> Share

    October 2025
  95. AYYAD M, Albandak M, Allencherril J
    Reclassifying myocardial infarction: from ST elevation to coronary occlusion.
    Eur Heart J. 2025 Oct 30:ehaf825. doi: 10.1093.
    >> Share

  96. MONTONE RA, Cosentino N, Gorla R, Biscaglia S, et al
    Stratified treatment of myocardial infarction with non-obstructive coronary arteries: the PROMISE trial.
    Eur Heart J. 2025 Oct 28:ehaf917. doi: 10.1093.
    >> Share

  97. LOMBARDI M, Boivin-Proulx LA, Jeronimo A, Mejia-Renteria H, et al
    Angina after percutaneous coronary interventions.
    Eur Heart J. 2025 Oct 17:ehaf771. doi: 10.1093.
    >> Share

  98. CREA F
    Ischaemic heart disease: changing landscape of risk stratification, importance of coronary stenosis functional assessment, optimal timing of anticoagulation in ST elevation myocardial infarction.
    Eur Heart J. 2025;46:3799-3804.
    >> Share

  99. ARAI R, Kojima K, Fukamachi D, Okumura Y, et al
    DanGer shock criteria and outcomes in acute myocardial infarction-related cardiogenic shock treated with Impella: the J-PVAD registry.
    Eur Heart J. 2025 Oct 13:ehaf787. doi: 10.1093.
    >> Share

  100. VERGALLO R, Pedicino D
    Weekly Journal Scan: An integrated rehabilitation strategy after myocardial infarction in older patients with impaired physical performance.
    Eur Heart J. 2025 Oct 9:ehaf780. doi: 10.1093.
    >> Share

  101. MEENA D, Huang J, Smith A, Yarmolinsky J, et al
    Blood pressure, plasma proteins, and cardiovascular diseases: a network Mendelian randomization and observational study.
    Eur Heart J. 2025 Oct 9:ehaf725. doi: 10.1093.
    >> Share

  102. DE SILVA R, Cheng K, Henry TD, Perera D, et al
    Refractory angina: mechanisms and stratified treatment in obstructive and non-obstructive chronic myocardial ischaemic syndromes.
    Eur Heart J. 2025;46:3738-3757.
    >> Share

    September 2025
  103. MUELLER C, White HD, Lopez-Ayala P, de Silva R, et al
    Great debate: the universal definition of myocardial infarction is flawed and should be put to rest.
    Eur Heart J. 2025 Sep 9:ehaf641. doi: 10.1093.
    >> Share


  104. Correction to: Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a Medicare population.
    Eur Heart J. 2025 Sep 8:ehaf708. doi: 10.1093.
    >> Share

  105. GIRAUD MN
    Macrophage leukotriene B4 production sustains inflammation after myocardial infarction.
    Eur Heart J. 2025 Sep 4:ehaf471. doi: 10.1093.
    >> Share

  106. CHEN Z, Song J, Feng S, Liu M, et al
    Arachidonic acid fuels inflammation by unlocking macrophage protein phosphatase 5 after myocardial infarction.
    Eur Heart J. 2025 Sep 4:ehaf493. doi: 10.1093.
    >> Share

  107. AMICONE S, Fedele D, Pizzi C
    Revascularization in latecomer ST-elevation myocardial infarction patients: diverging ACC/AHA and ESC Guidelines.
    Eur Heart J. 2025 Sep 3:ehaf616. doi: 10.1093.
    >> Share

  108. GOULD KL, Johnson NP, Roby AE, Kirkeeide R, et al
    Optimal medical care and coronary flow capacity-guided myocardial revascularization vs usual care for chronic coronary artery disease: the CENTURY trial.
    Eur Heart J. 2025;46:3273-3286.
    >> Share

    August 2025
  109. KANG DY, Wee SB, Ahn JM, Park H, et al
    Temporal modulation of antiplatelet therapy in high-risk patients undergoing complex percutaneous coronary intervention: the TAILORED-CHIP randomized clinical trial.
    Eur Heart J. 2025 Aug 31:ehaf652. doi: 10.1093.
    >> Share

  110. KINDBORG G, Eriksson Hogling D, Habel H, Yan J, et al
    Major cardiovascular events in first-degree relatives of individuals with elevated plasma lipoprotein(a): a registry-based cohort study.
    Eur Heart J. 2025 Aug 31:ehaf677. doi: 10.1093.
    >> Share

  111. ROSSELLO X, Dominguez-Rodriguez A, Latini R, Sanchez PL, et al
    Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trial.
    Eur Heart J. 2025 Aug 30:ehaf673. doi: 10.1093.
    >> Share

  112. DILLINGER JG, Pezel T, Batias L, Angoulvant D, et al
    Aspirin dosing after acute coronary syndrome with suspected aspirin resistance: the ANDAMAN trial.
    Eur Heart J. 2025 Aug 30:ehaf680. doi: 10.1093.
    >> Share

  113. WENZL FA, Wang P, Kahles F, Beck KR, et al
    Gut microbiota-derived imidazole propionate predicts cardiometabolic risk in patients with coronary artery disease.
    Eur Heart J. 2025 Aug 30:ehaf661. doi: 10.1093.
    >> Share

  114. KAWAGUCHI N, Ando R, Obata J
    A case of cardiopulmonary arrest on arrival due to acute myocardial infarction with immunoglobulin G4-related coronary periarteritis.
    Eur Heart J. 2025 Aug 29:ehaf632. doi: 10.1093.
    >> Share

  115. MANGIACAPRA F, Paolucci L, De Bruyne B, Rioufol G, et al
    Fractional flow reserve vs angiography to guide percutaneous coronary intervention: an individual patient data meta-analysis.
    Eur Heart J. 2025 Aug 20:ehaf504. doi: 10.1093.
    >> Share

  116. LI F, Flynn E, Ha P, Zebak MN, et al
    LIPA, a risk locus for coronary artery disease: decoding the variant-to-function relationship.
    Eur Heart J. 2025 Aug 19:ehaf581. doi: 10.1093.
    >> Share

  117. KRALER S, Mueller C, Libby P, Bhatt DL, et al
    Acute coronary syndromes: mechanisms, challenges, and new opportunities.
    Eur Heart J. 2025;46:2866-2889.
    >> Share

  118. CHEN J, Xu C, Qiu L, Li B, et al
    Heparin administration at first medical contact vs immediately before primary percutaneous coronary intervention: the HELP-PCI trial.
    Eur Heart J. 2025 Aug 1:ehaf481. doi: 10.1093.
    >> Share

    July 2025

  119. Correction to: Scpep1 inhibition attenuates myocardial infarction-induced dysfunction by improving mitochondrial bioenergetics.
    Eur Heart J. 2025 Jul 31:ehaf579. doi: 10.1093.
    >> Share

  120. PARADIES V, Masiero G, Rubboli A, Van Beusekom HMM, et al
    Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
    Eur Heart J. 2025;46:2730-2741.
    >> Share

  121. MORZE J, Melloni GEM, Wittenbecher C, Ala-Korpela M, et al
    ApoB-containing lipoproteins: count, type, size, and risk of coronary artery disease.
    Eur Heart J. 2025;46:2691-2701.
    >> Share


  122. Correction to: Beta-blocker interruption effects on blood pressure and heart rate after myocardial infarction: the AbetaYSS trial.
    Eur Heart J. 2025 Jul 10:ehaf510. doi: 10.1093.
    >> Share

  123. FEZZI S, Scheller B, Cortese B, Alfonso F, et al
    Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium.
    Eur Heart J. 2025;46:2498-2519.
    >> Share

  124. NURMOHAMED NS, Ngo-Metzger Q, Taub PR, Ray KK, et al
    First myocardial infarction: risk factors, symptoms, and medical therapy.
    Eur Heart J. 2025 Jul 3:ehaf390. doi: 10.1093.
    >> Share

    June 2025
  125. MILLER RJH, Yi J, Shanbhag A, Marcinkiewicz A, et al
    Deep learning-quantified body composition from positron emission tomography/computed tomography and cardiovascular outcomes: a multicentre study.
    Eur Heart J. 2025;46:2336-2347.
    >> Share

  126. WANG S, Luo X, Hu S, Zhao C, et al
    Plaque erosion risk and JAK2 V617F variant.
    Eur Heart J. 2025;46:2205-2219.
    >> Share

  127. WANG X, Xu Y, Yu C, Deng R, et al
    Periodontitis-related myocardial fibrosis by expansion of collagen-producing SiglecF+ neutrophils.
    Eur Heart J. 2025;46:2223-2238.
    >> Share

  128. TOVAL A, Bakker EA, Granada-Maia JB, Nunez de Arenas-Arroyo S, et al
    Exercise type and settings, quality of life, and mental health in coronary artery disease: a network meta-analysis.
    Eur Heart J. 2025;46:2186-2201.
    >> Share

  129. ZEDER K, Mak S, Galie N, Rosenkranz S, et al
    Right heart catheterization in heart failure: indications, interpretation, and pitfalls.
    Eur Heart J. 2025 Jun 16:ehaf322. doi: 10.1093.
    >> Share

  130. HASSAN IN, Ashraf H, Hasan A
    Sudan conflict: impact on interrupted care after acute myocardial infarction.
    Eur Heart J. 2025 Jun 12:ehaf313. doi: 10.1093.
    >> Share

  131. ARENAS-MONTES J, Alcala-Diaz JF, Garcia-Fernandez H, Gutierrez-Mariscal FM, et al
    A microbiota pattern associated with cardiovascular events in secondary prevention: the CORDIOPREV study.
    Eur Heart J. 2025;46:2104-2115.
    >> Share

  132. RYAN M, Petrie MC, Kontopantelis E, Dodd M, et al
    Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysis.
    Eur Heart J. 2025;46:2052-2062.
    >> Share

  133. MAHENDIRAN T, Bouisset F, Tonino P, Pijls NHJ, et al
    Titanium-nitride-oxide-coated vs. drug-eluting stents in acute coronary syndromes: an individual patient data meta-analysis.
    Eur Heart J. 2025;46:2092-2100.
    >> Share

  134. ALI ZA, Shin D, Vijayvergiya R, Gawalkar AA, et al
    Optical coherence tomography- vs angiography-guided coronary stent implantation in calcified lesions: the ILUMIEN IV trial.
    Eur Heart J. 2025 Jun 5:ehaf331. doi: 10.1093.
    >> Share

    May 2025
  135. KIM MC, Park SJ, Park DW, Ahn JM, et al
    Preventive percutaneous coronary intervention for non-flow-limiting vulnerable atherosclerotic coronary plaques in diabetes: the PREVENT trial.
    Eur Heart J. 2025 May 29:ehaf273. doi: 10.1093.
    >> Share

  136. PROCOPI N, Zeitouni M, Kerneis M, Cayla G, et al
    Beta-blocker interruption effects on blood pressure and heart rate after myocardial infarction: the AbetaYSS trial.
    Eur Heart J. 2025 May 22:ehaf170. doi: 10.1093.
    >> Share

  137. CLELAND JGF
    Staring into the AbetaYSS: how many pills and for how long after myocardial infarction?
    Eur Heart J. 2025 May 22:ehaf226. doi: 10.1093.
    >> Share

  138. HANSSON EC, Omerovic E, Venetsanos D, Alfredsson J, et al
    Coronary artery bypass grafting with or without preoperative physiological stenosis assessment: a SWEDEHEART study.
    Eur Heart J. 2025 May 16:ehaf327. doi: 10.1093.
    >> Share

  139. COYLE M, McEvoy JW
    Age-specific troponin thresholds: considerations for the fifth universal definition of myocardial infarction.
    Eur Heart J. 2025 May 9:ehaf308. doi: 10.1093.
    >> Share

  140. WANG J, Verkerk AO, Wilders R, Zhang Y, et al
    SCN10A-short gene therapy to restore conduction and protect against malignant cardiac arrhythmias.
    Eur Heart J. 2025;46:1747-1762.
    >> Share

  141. PERRY CGR, Sweeney G
    Targeting mitochondrial fission for the treatment of myocardial infarction.
    Eur Heart J. 2025 May 6:ehaf296. doi: 10.1093.
    >> Share

  142. OIKONOMOU G, Cheng K, Mohiaddin RH
    CMR: a gatekeeper before ICA in a stable non ST-elevation myocardial infarction patient with severely impaired LV function.
    Eur Heart J. 2025 May 6:ehaf300. doi: 10.1093.
    >> Share

  143. FEZZI S, Giacoppo D, Fahrni G, Latib A, et al
    Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA study.
    Eur Heart J. 2025;46:1586-1599.
    >> Share

  144. WEYRICH M, Zewinger S, Sarakpi T, Rasper T, et al
    Mosaic loss of Y chromosome and mortality after coronary angiography.
    Eur Heart J. 2025;46:1603-1616.
    >> Share

  145. ZHANG Q, Li H, Zhuang T, Xu L, et al
    CCN5 suppresses injury-induced vascular restenosis by inhibiting smooth muscle cell proliferation and facilitating endothelial repair via thymosin beta4 and Cd9 pathway.
    Eur Heart J. 2025;46:1645-1658.
    >> Share

  146. D'ENTREMONT MA, Poorthuis MHF, Fiolet ATL, Amarenco P, et al
    Colchicine for secondary prevention of vascular events: a meta-analysis of trials.
    Eur Heart J. 2025 May 2:ehaf210. doi: 10.1093.
    >> Share

  147. SAMUEL M, Berry C, Dube MP, Koenig W, et al
    Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis.
    Eur Heart J. 2025 May 2:ehaf174. doi: 10.1093.
    >> Share

    April 2025
  148. CREA F
    Focus on heart failure: sex-related differences, new light shed on SGLT2i mechanism of action, and heart failure after myocardial infarction.
    Eur Heart J. 2025;46:1457-1461.
    >> Share

  149. MOLLER JE, Thiele H, Morrow D, Kjaergaard J, et al
    Mechanical circulatory support: when, how, and for whom.
    Eur Heart J. 2025;46:1480-1492.
    >> Share

  150. CHEN J, Zhao J, Fu S
    Addressing sample overlap and meta-analysis imbalances in Mendelian randomization: a critical appraisal of protein targets for myocardial infarction.
    Eur Heart J. 2025 Apr 18:ehaf186. doi: 10.1093.
    >> Share

  151. TITOVA OE, Yuan S, Larsson SC
    Applying Mendelian randomization to study the relationship between circulating proteins and myocardial infarction.
    Eur Heart J. 2025 Apr 18:ehaf187. doi: 10.1093.
    >> Share

  152. BAY B, Tanner R, Gao M, Oliva A, et al
    Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary interventiondagger.
    Eur Heart J. 2025 Apr 10:ehaf196. doi: 10.1093.
    >> Share

  153. BOUGHANEM H, Herrero-Cervera A, Soehnlein O
    SiglecF+ neutrophils link periodontitis to impaired post-myocardial infarction repair.
    Eur Heart J. 2025 Apr 8:ehaf165. doi: 10.1093.
    >> Share

    March 2025
  154. BUSCHER A, Plagwitz L, Yildirim K, Brix TJ, et al
    Deep Learning Electrocardiogram Model for Risk Stratification of Coronary Revascularization Need in the Emergency Department.
    Eur Heart J. 2025 Mar 29:ehaf254. doi: 10.1093.
    >> Share

  155. CHIU IM, Ouyang D
    Acute myocardial infarction diagnosis: impact of artificial intelligence-powered ECG interpretation.
    Eur Heart J. 2025 Mar 25:ehaf142. doi: 10.1093.
    >> Share

  156. SOUZA ACDAH, Troschel AS, Marquardt JP, Hadzic I, et al
    Skeletal muscle adiposity, coronary microvascular dysfunction, and adverse cardiovascular outcomes.
    Eur Heart J. 2025;46:1112-1123.
    >> Share

  157. XU Y, Feng T, Huang Y
    Gender-specific associations and circulating proteins in myocardial infarction: potential causal relationships.
    Eur Heart J. 2025 Mar 7:ehaf111. doi: 10.1093.
    >> Share

  158. TITOVA OE, Yuan S, Byberg L, Baron JA, et al
    Circulating proteins and incident myocardial infarction: appraising sex-specific differences and causality.
    Eur Heart J. 2025 Mar 7:ehaf113. doi: 10.1093.
    >> Share

  159. BOUZID Z, Sejdic E, Martin-Gill C, Faramand Z, et al
    Electrocardiogram-based machine learning for risk stratification of patients with suspected acute coronary syndrome.
    Eur Heart J. 2025;46:943-954.
    >> Share

  160. CLAESSEN G, Eijsvogels TMH, Albert CM, Baggish AL, et al
    Coronary atherosclerosis in athletes: emerging concepts and preventive strategies.
    Eur Heart J. 2025;46:890-903.
    >> Share

  161. CALAFIORE AM, Prapas S, Gaudino M
    Arterial conduits for coronary bypass grafting: the set-point concept.
    Eur Heart J. 2025;46:922-925.
    >> Share

  162. DANG QM, Psaltis PJ, Burgess S, Chandrasekhar J, et al
    The Australian-New Zealand spontaneous coronary artery dissection cohort study: predictors of major adverse cardiovascular events and recurrence.
    Eur Heart J. 2025 Mar 7:ehaf097. doi: 10.1093.
    >> Share

    February 2025
  163. LEE MS, Shin TG, Lee Y, Kim DH, et al
    Artificial intelligence applied to electrocardiogram to rule out acute myocardial infarction: the ROMIAE multicentre study.
    Eur Heart J. 2025 Feb 24:ehaf004. doi: 10.1093.
    >> Share

  164. CHEN G, Gan J, Wu F, Zhou Z, et al
    Scpep1 inhibition attenuates myocardial infarction-induced dysfunction by improving mitochondrial bioenergetics.
    Eur Heart J. 2025 Feb 11:ehaf032. doi: 10.1093.
    >> Share

  165. SQUIRE IB, Sze S
    Prognosis following acute myocardial infarction.
    Eur Heart J. 2025 Feb 10:ehaf056. doi: 10.1093.
    >> Share

  166. ROMAN M, Miksza J, Lai FY, Sze S, et al
    Revascularization in frail patients with acute coronary syndromes: a retrospective longitudinal study.
    Eur Heart J. 2025;46:535-547.
    >> Share

  167. CREA F
    Focus on the extreme of the spectrum: myocardial infarction with no obstructive coronary arteries and ischaemic cardiomyopathy.
    Eur Heart J. 2025;46:399-403.
    >> Share

  168. RASMUSSEN LD, Schmidt SE, Knuuti J, Vrints C, et al
    Clinical risk prediction, coronary computed tomography angiography, and cardiovascular events in new-onset chest pain: the PROMISE and SCOT-HEART trials.
    Eur Heart J. 2025;46:473-483.
    >> Share

  169. RASMUSSEN LD, Westra J, Karim SR, Dahl JN, et al
    Microvascular resistance reserve: impact on health status and myocardial perfusion after revascularization in chronic coronary syndrome.
    Eur Heart J. 2025;46:424-435.
    >> Share

    January 2025
  170. BUTLER J, Hammonds K, Talha KM, Alhamdow A, et al
    Incident heart failure and recurrent coronary events following acute myocardial infarction.
    Eur Heart J. 2025 Jan 28:ehae885. doi: 10.1093.
    >> Share

  171. PEDICINO D, Volpe M
    Weekly Journal Scan: A CLEAR message questions the routine use of spironolactone in acute myocardial infarction.
    Eur Heart J. 2025 Jan 21:ehae936. doi: 10.1093.
    >> Share

  172. REEH J, Afzal S, Wulff AB, Nordestgaard BG, et al
    Ages at coronary heart disease and death in familial hypercholesterolaemia: a Danish nationwide study spanning 44 years.
    Eur Heart J. 2025 Jan 17:ehae912. doi: 10.1093.
    >> Share

  173. LIUZZO G, Patrono C
    Weekly Journal Scan: no CLEAR evidence of cardiovascular benefits of colchicine after acute myocardial infarction.
    Eur Heart J. 2025 Jan 9:ehae897. doi: 10.1093.
    >> Share

  174. WILKINSON C, Bhatty A, Batra G, Aktaa S, et al
    Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).
    Eur Heart J. 2025;46:190-214.
    >> Share

  175. BJERKING LH, Skak-Hansen KW, Heitmann M, Hove JD, et al
    Acoustic-based rule-out of stable coronary artery disease: the FILTER-SCAD trial.
    Eur Heart J. 2025;46:117-128.
    >> Share

  176. WENZL FA, Wang P, Arrigo M, Parenica J, et al
    Proenkephalin improves cardio-renal risk prediction in acute coronary syndromes: the KID-ACS score.
    Eur Heart J. 2025;46:38-54.
    >> Share

    December 2024
  177. ZHANG Y, Yu S, Chen Z, Liu H, et al
    Gestational diabetes and future cardiovascular diseases: associations by sex-specific genetic data.
    Eur Heart J. 2024;45:5156-5167.
    >> Share

  178. PEDICINO D, Volpe M
    Weekly Journal Scan: The jury is still out on beta-blockers following acute myocardial infarction with preserved ejection fraction after the ABYSS trial.
    Eur Heart J. 2024 Dec 14:ehae858. doi: 10.1093.
    >> Share

  179. CHAPMAN AR, Taggart C, Boeddinghaus J, Mills NL, et al
    Type 2 myocardial infarction: challenges in diagnosis and treatment.
    Eur Heart J. 2024 Dec 10:ehae803. doi: 10.1093.
    >> Share

    November 2024
  180. BACK M, Hofmann R
    Myocardial infarction and low ambient temperature: does presence or absence of stenoses make a difference?
    Eur Heart J. 2024 Nov 28:ehae820. doi: 10.1093.
    >> Share

  181. AI L, de Freitas Germano J, Huang C, Aniag M, et al
    Enhanced Parkin-mediated mitophagy mitigates adverse left ventricular remodelling after myocardial infarction: role of PR-364.
    Eur Heart J. 2024 Nov 27:ehae782. doi: 10.1093.
    >> Share

  182. OMEROVIC E, Ramunddal T, Petursson P, Angeras O, et al
    Percutaneous vs. surgical revascularization of non-ST-segment elevation myocardial infarction with multivessel disease: the SWEDEHEART registry.
    Eur Heart J. 2024 Nov 27:ehae700. doi: 10.1093.
    >> Share

  183. NARAYANAN S, Vuckovic S, Bergman O, Wirka R, et al
    Atheroma transcriptomics identifies ARNTL as a smooth muscle cell regulator and with clinical and genetic data improves risk stratification.
    Eur Heart J. 2024 Nov 18:ehae768. doi: 10.1093.
    >> Share

  184. BENDRISS E, Pasqueron J, Bardon J
    Coronary air embolism causing myocardial infarction following a blunt chest trauma.
    Eur Heart J. 2024 Nov 14:ehae771. doi: 10.1093.
    >> Share

  185. WANG Y, Zeller M, Auffret V, Georgiopoulos G, et al
    Sex-specific prediction of cardiogenic shock after acute coronary syndromes: the SEX-SHOCK score.
    Eur Heart J. 2024;45:4564-4578.
    >> Share

  186. ZURIAGA MA, Yu Z, Matesanz N, Truong B, et al
    Colchicine prevents accelerated atherosclerosis in TET2-mutant clonal haematopoiesis.
    Eur Heart J. 2024;45:4601-4615.
    >> Share

  187. LANDMESSER U, Ali ZA, Maehara A, Matsumura M, et al
    Optical coherence tomography predictors of clinical outcomes after stent implantation: the ILUMIEN IV trial.
    Eur Heart J. 2024;45:4630-4643.
    >> Share

    October 2024
  188. BLOOM JE, Vogrin S, Reid CM, Ajani AE, et al
    Coronary artery bypass grafting vs. percutaneous coronary intervention in severe ischaemic cardiomyopathy: long-term survival.
    Eur Heart J. 2024 Oct 29:ehae672. doi: 10.1093.
    >> Share

  189. HUANG J, He Q, Jiang Y, Wong JMJ, et al
    Low ambient temperature and incident myocardial infarction with or without obstructive coronary arteries: a Chinese nationwide study.
    Eur Heart J. 2024 Oct 28:ehae711. doi: 10.1093.
    >> Share

  190. KANG D, Choi KH, Kim H, Park H, et al
    Prognosis after switching to electronic cigarettes following percutaneous coronary intervention: a Korean nationwide study.
    Eur Heart J. 2024 Oct 21:ehae705. doi: 10.1093.
    >> Share

  191. KARAKASIS P, Pamporis K, Siontis KC, Theofilis P, et al
    Major clinical outcomes in symptomatic vs. asymptomatic atrial fibrillation: a meta-analysis.
    Eur Heart J. 2024 Oct 21:ehae694. doi: 10.1093.
    >> Share

  192. CHARTON J, Bouteiller X, Gandjbakhch E, Waintraub X, et al
    Overdrive pacing for ventricular fibrillation storm after myocardial infarction.
    Eur Heart J. 2024 Oct 18:ehae698. doi: 10.1093.
    >> Share

  193. LIUZZO G, Patrono C
    Weekly Journal Scan: Do older patients with non-ST-segment elevation myocardial infarction receive any benefit from a routine invasive strategy?
    Eur Heart J. 2024 Oct 18:ehae684. doi: 10.1093.
    >> Share

  194. RAJAKULASINGAM R, Ferreira PF, Scott AD, Khalique Z, et al
    Characterization of dynamic changes in cardiac microstructure after reperfused ST-elevation myocardial infarction by biphasic diffusion tensor cardiovascular magnetic resonance.
    Eur Heart J. 2024 Oct 15:ehae667. doi: 10.1093.
    >> Share

  195. CREA F
    Focus on ischaemic heart disease: secondary prevention, cardiogenic shock, and novel therapeutic targets.
    Eur Heart J. 2024;45:4141-4144.
    >> Share

  196. TITOVA OE, Yuan S, Byberg L, Baron JA, et al
    Plasma proteome and incident myocardial infarction: sex-specific differences.
    Eur Heart J. 2024 Oct 14:ehae658. doi: 10.1093.
    >> Share

  197. BARTON AK, Lau ES, Gulati M
    Steps towards curing Yentl syndrome: appraising sex differences in circulating proteins and incident myocardial infarction.
    Eur Heart J. 2024 Oct 14:ehae657. doi: 10.1093.
    >> Share

  198. DESCH S, Zeymer U, Akin I, Behnes M, et al
    Routine extracorporeal life support in infarct-related cardiogenic shock: 1-year results of the ECLS-SHOCK trial.
    Eur Heart J. 2024;45:4200-4203.
    >> Share

  199. WEINTRAUB WS, Boden WE
    Achieving successful prevention of coronary artery disease: a worldwide call to action.
    Eur Heart J. 2024;45:4197-4199.
    >> Share

  200. LUSEBRINK E, Binzenhofer L, Thiele H
    The DanGer Shock trial: a new dawn but much to uncover.
    Eur Heart J. 2024;45:4181-4183.
    >> Share

  201. LUSCHER TF, Thiele H
    Cardiogenic shock: do we need a paradigm shift?
    Eur Heart J. 2024;45:4178-4180.
    >> Share


  202. Correction to: Great debate: myocardial infarction after cardiac surgery must be redefined.
    Eur Heart J. 2024 Oct 11:ehae734. doi: 10.1093.
    >> Share

  203. AJUFO EC, Tedrow UB
    Refining the stratification of sudden cardiac death risk after myocardial infarction-beyond ejection fraction.
    Eur Heart J. 2024 Oct 8:ehae272. doi: 10.1093.
    >> Share

  204. PEEK N, Hindricks G, Akbarov A, Tijssen JGP, et al
    Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts.
    Eur Heart J. 2024 Oct 8:ehae326. doi: 10.1093.
    >> Share

  205. SHIMADA T, Fujisawa N, Otsuka K
    Intracoronary polarimetric signatures of exercise-induced vasospastic angina.
    Eur Heart J. 2024;45:3894.
    >> Share

    September 2024
  206. XU Y, Li H, Santosa A, Wettermark B, et al
    Cardiovascular events following coronavirus disease 2019 vaccination in adults: a nationwide Swedish study.
    Eur Heart J. 2024 Sep 30:ehae639. doi: 10.1093.
    >> Share

  207. CREA F
    New Guidelines and a focus on ischaemic heart disease, atrial fibrillation, innovative treatments of channelopathies.
    Eur Heart J. 2024;45:3299-3302.
    >> Share

  208. BAIREY MERZ CN
    Vulnerable plaque and major adverse cardiovascular events: anatomy of a failure.
    Eur Heart J. 2024;45:3748-3750.
    >> Share

  209. BODEN WE, De Caterina R, Kaski JC, Bairey Merz N, et al
    Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving international clinical practice guidelines.
    Eur Heart J. 2024;45:3701-3706.
    >> Share

  210. VRINTS C, Andreotti F, Koskinas KC, Rossello X, et al
    2024 ESC Guidelines for the management of chronic coronary syndromes.
    Eur Heart J. 2024;45:3415-3537.
    >> Share

  211. NURMOHAMED NS, Min JK, Anthopolos R, Reynolds HR, et al
    Atherosclerosis quantification and cardiovascular risk: the ISCHEMIA trial.
    Eur Heart J. 2024;45:3735-3747.
    >> Share

  212. VERGALLO R, Liuzzo G
    Weekly Journal Scan: The prognostic value of coronary inflammation in patients with non-obstructive coronary artery disease.
    Eur Heart J. 2024;45:3311-3313.
    >> Share

  213. PEDICINO D, Volpe M
    Weekly Journal Scan: increased incidence of acute myocardial infarction in patients with laboratory-confirmed influenza infection.
    Eur Heart J. 2024 Sep 25:ehae569. doi: 10.1093.
    >> Share

  214. ECHIVARD M, Sellal JM, Ziliox C, Marijon E, et al
    Prognostic value of ventricular arrhythmia in early post-infarction left ventricular dysfunction: the French nationwide WICD-MI study.
    Eur Heart J. 2024 Sep 20:ehae575. doi: 10.1093.
    >> Share

  215. GAUDINO M, Jaffe AS, Milojevic M, Sandoval Y, et al
    Great debate: myocardial infarction after cardiac surgery must be redefined.
    Eur Heart J. 2024 Sep 16:ehae416. doi: 10.1093.
    >> Share

  216. BADIMON L, Kiss A, Podesser BK
    Spleen in action for cardioprotection.
    Eur Heart J. 2024;45:3178-3180.
    >> Share

  217. NISHI T, Kume T, Saito Y, Kato K, et al
    Intraplaque haemorrhage, coronary spasm, and resuscitated cardiac arrest in patients with non-obstructive coronary artery disease.
    Eur Heart J. 2024;45:3181-3183.
    >> Share

  218. LIUZZO G, Patrono C
    Weekly Journal Scan: a penULTIMATE frontier for optimal antiplatelet therapy after drug-eluting stenting in acute coronary syndromes?
    Eur Heart J. 2024;45:3108-3110.
    >> Share

  219. LIEDER HR, Paket U, Skyschally A, Rink AD, et al
    Vago-splenic signal transduction of cardioprotection in humans.
    Eur Heart J. 2024;45:3164-3177.
    >> Share

  220. GIBSON CM, Duffy D, Bahit MC, Chi G, et al
    Apolipoprotein A-I Infusions and Cardiovascular Outcomes in Acute Myocardial Infarction According to Baseline LDL-Cholesterol Levels: The AEGIS-II Trial.
    Eur Heart J. 2024 Sep 2:ehae614. doi: 10.1093.
    >> Share

  221. HAVERS-BORGERSEN E, Hartwell D, Ekelund C, Butt JH, et al
    Endometriosis and Long-Term Cardiovascular Risk: A Nationwide Danish study.
    Eur Heart J. 2024 Sep 2:ehae563. doi: 10.1093.
    >> Share

  222. SCHNABEL RB, Benezet-Mazuecos J, Becher N, McIntyre WF, et al
    Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials.
    Eur Heart J. 2024 Sep 2:ehae596. doi: 10.1093.
    >> Share

  223. TANIWAKI M, Haner JD, Kakizaki R, Ohno Y, et al
    Long-term effect of biodegradable vs durable polymer everolimus-eluting stents on neoatherosclerosis in ST-segment elevation myocardial infarction: the CONNECT trial.
    Eur Heart J. 2024 Sep 1:ehae589. doi: 10.1093.
    >> Share

  224. EITEL I, Saraei R, Jurczyk D, Fach A, et al
    Glycoprotein IIb/IIIa Inhibitors in Acute Myocardial Infarction and Angiographic Microvascular Obstruction: The REVERSE-FLOW Trial.
    Eur Heart J. 2024 Sep 1:ehae587. doi: 10.1093.
    >> Share

  225. SCHUBERT J, Leosdottir M, Lindahl B, Westerberg J, et al
    Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry.
    Eur Heart J. 2024 Sep 1:ehae576. doi: 10.1093.
    >> Share

  226. VAN DEN BROEK WWA, Ten Berg JM
    The puzzle of antiplatelet therapy in ACS: ticagrelor monotherapy is another missing piece.
    Eur Heart J. 2024;45:3057-3059.
    >> Share

  227. PRENDERGAST BD, Patterson T, Redwood S
    Acute coronary occlusion during valve-in-valve TAVI-a shortcut to successful prevention.
    Eur Heart J. 2024;45:3042-3044.
    >> Share

    August 2024
  228. ONDRACEK AS, Afonyushkin T, Aszlan A, Taqi S, et al
    Malondialdehyde-specific natural IgM inhibit NETosis triggered by culprit site-derived extracellular vesicles from myocardial infarction patients.
    Eur Heart J. 2024 Aug 31:ehae584. doi: 10.1093.
    >> Share

  229. GERHARDT T, Landmesser U
    Malondialdehyde-specific natural IgM inhibit NETosis triggered by coronary extracellular vesicles of myocardial infarction patients.
    Eur Heart J. 2024 Aug 31:ehae554. doi: 10.1093.
    >> Share

  230. WATANABE H, Natsuaki M, Morimoto T, Yamamoto K, et al
    Aspirin versus Clopidogrel Monotherapy After Percutaneous Coronary Intervention: 1-Year Follow-up of the STOPDAPT-3 Trial.
    Eur Heart J. 2024 Aug 31:ehae617. doi: 10.1093.
    >> Share


  231. Correction to: Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score.
    Eur Heart J. 2024 Aug 30:ehae581. doi: 10.1093.
    >> Share

  232. MCEVOY JW, Jennings C, Kotseva K, De Bacquer D, et al
    Variation in Secondary Prevention of Coronary Heart Disease: The INTERASPIRE Study.
    Eur Heart J. 2024 Aug 30:ehae558. doi: 10.1093.
    >> Share

  233. TARDIF JC, Ouellette K, Boulet J
    Colchicine improves outcomes in coronary disease, but will it in heart failure?
    Eur Heart J. 2024 Aug 30:ehae612. doi: 10.1093.
    >> Share

  234. MAHAFFEY KW, Tuttle KR, Arici M, Baeres FMM, et al
    Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial.
    Eur Heart J. 2024 Aug 30:ehae613. doi: 10.1093.
    >> Share

  235. CREA F
    Expanding knowledge in atrial fibrillation, blood pressure treatment, and management of coronary and peripheral artery disease.
    Eur Heart J. 2024;45:2795-2799.
    >> Share

  236. PAVASINI R, Biscaglia S, Kunadian V, Hakeem A, et al
    Coronary artery disease management in older adults: revascularization and exercise training.
    Eur Heart J. 2024;45:2811-2823.
    >> Share

  237. CREA F
    Heart failure and ischaemic heart disease: new challenges and opportunities.
    Eur Heart J. 2024;45:2681-2685.
    >> Share

  238. BURZOTTA F, Zito A, Aurigemma C, Romagnoli E, et al
    Fractional flow reserve or optical coherence tomography for angiographically intermediate coronary stenoses: 5-year outcomes in the FORZA trial.
    Eur Heart J. 2024;45:2785-2788.
    >> Share

  239. VOLLEBERG R, Damman P, van Royen N
    Dissection-like appearance of focal catheter-induced vasospasm in intracoronary optical coherence tomography.
    Eur Heart J. 2024;45:2793.
    >> Share

  240. CIULLO A, Li L, Li C, Tsi K, et al
    Non-coding RNA yREX3 from human extracellular vesicles exerts macrophage-mediated cardioprotection via a novel gene-methylating mechanism.
    Eur Heart J. 2024;45:2660-2673.
    >> Share

  241. PEDICINO D, Vergallo R
    Weekly Journal Scan: Drug-coated balloon for the treatment of in-stent restenosis - the AGENT IDE trial.
    Eur Heart J. 2024;45:2592-2593.
    >> Share

    July 2024
  242. LIUZZO G, Patrono C
    Weekly Journal Scan: apolipoprotein A1 is not an adequate shield against early vascular events after acute myocardial infarction.
    Eur Heart J. 2024 Jul 26:ehae446. doi: 10.1093.
    >> Share

  243. BESOLA L, Colli A, De Caterina R
    Coronary bypass surgery for multivessel disease after percutaneous coronary intervention in acute coronary syndromes: why, for whom, how early?
    Eur Heart J. 2024 Jul 26:ehae413. doi: 10.1093.
    >> Share

  244. KANG J, Yun J, Park KW, Park M, et al
    Long-term outcomes of high bleeding risk patients undergoing percutaneous coronary intervention: a Korean nationwide registry.
    Eur Heart J. 2024 Jul 23:ehae462. doi: 10.1093.
    >> Share

  245. CREA F
    Focus on acute myocardial infarction, sex-related differences in coronary bypass surgery, inflammation in heart failure, and infective endocarditis in prosthetic valves.
    Eur Heart J. 2024;45:2463-2467.
    >> Share

  246. GIANNITSIS E, Frey N, Katus HA
    Accelerated high sensitivity troponin diagnostics: ready for an even faster pace?
    Eur Heart J. 2024;45:2516-2518.
    >> Share

  247. DIEZ BENAVENTE E, Sakkers TR, van der Harst P, den Ruijter HM, et al
    Atherosclerotic plaque-specific methylation biomarkers in plasma cell-free DNA of female and male patients with coronary artery disease.
    Eur Heart J. 2024;45:2468-2470.
    >> Share

  248. AHMAD Y, Lansky AJ
    Periprocedural myocardial infarction: thresholds of (in)significance.
    Eur Heart J. 2024 Jul 19:ehae451. doi: 10.1093.
    >> Share

  249. JURADO-ROMAN A, Agudo-Quilez P
    Tailoring antithrombotic treatment in patients with acute myocardial infarction and cancer: virtue lies in balance.
    Eur Heart J. 2024 Jul 19:ehae445. doi: 10.1093.
    >> Share

  250. DAFAALLA M, Costa F, Kontopantelis E, Araya M, et al
    Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score.
    Eur Heart J. 2024 Jul 17:ehae463. doi: 10.1093.
    >> Share

  251. FIGTREE GA, Gray MP
    Improving clinical outcomes for patients with coronary artery disease despite no standard modifiable cardiovascular risk factors (SMuRF): not out of the woods yet.
    Eur Heart J. 2024;45:2407-2409.
    >> Share

  252. ROGER G, Ducrocq G, Mesnier J, Sayah N, et al
    Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry.
    Eur Heart J. 2024;45:2396-2406.
    >> Share

  253. BEKKI M, Tahara N, Fukumoto Y
    Primary cardiac lymphoma causing coronary artery compression and massive tricuspid regurgitation.
    Eur Heart J. 2024 Jul 2:ehae390. doi: 10.1093.
    >> Share

    June 2024
  254. SCHELDEMAN L, Sinnaeve P, Albers GW, Lemmens R, et al
    Acute myocardial infarction and ischaemic stroke: differences and similarities in reperfusion therapies-a review.
    Eur Heart J. 2024 Jun 28:ehae371. doi: 10.1093.
    >> Share

  255. VILAHUR G, Radike M, Badimon L
    Novel cardioprotective approaches in ischaemic heart disease.
    Eur Heart J. 2024;45:2109-2111.
    >> Share

  256. HOLFELD J, Nagele F, Polzl L, Engler C, et al
    Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial.
    Eur Heart J. 2024 Jun 20:ehae341. doi: 10.1093.
    >> Share

  257. SCHLOTTER F, Huber K, Hassager C, Halvorsen S, et al
    Ventricular septal defect complicating acute myocardial infarction: diagnosis and management. A Clinical Consensus Statement of the Association for Acute CardioVascular Care (ACVC) of the ESC, the European Association of Percutaneous Cardiovascular In
    Eur Heart J. 2024 Jun 18:ehae363. doi: 10.1093.
    >> Share

  258. PEDICINO D, Volpe M
    Weekly Journal Scan: do we need beta-blockers after myocardial infarction with preserved ejection fraction?
    Eur Heart J. 2024 Jun 14:ehae368. doi: 10.1093.
    >> Share

  259. COUGHLAN JJ, Durand R, Byrne RA
    An initial invasive strategy in older patients with non-ST elevation acute coronary syndromes: it is never too late.
    Eur Heart J. 2024;45:2063-2065.
    >> Share

  260. KOTANIDIS CP, Mills GB, Bendz B, Berg ES, et al
    Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis.
    Eur Heart J. 2024;45:2052-2062.
    >> Share

  261. BEERKENS FJ, Bhatt DL
    Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: is a routine invasive strategy needed?
    Eur Heart J. 2024 Jun 7:ehae287. doi: 10.1093.
    >> Share

  262. CULLEN L, Greenslade J, Parsonage W, Stephensen L, et al
    Point-of-care high-sensitivity cardiac troponin in suspected acute myocardial infarction assessed at baseline and 2 h.
    Eur Heart J. 2024 Jun 6:ehae343. doi: 10.1093.
    >> Share

  263. LIUZZO G, Patrono C
    Weekly Journal Scan: sodium/glucose cotransporter 2 inhibition after myocardial infarction still in the grey area.
    Eur Heart J. 2024 Jun 1:ehae304. doi: 10.1093.
    >> Share

  264. VERGALLO R, Pedicino D
    Weekly Journal Scan: Impella CP in myocardial infarction complicated by cardiogenic shock.
    Eur Heart J. 2024 Jun 1:ehae306. doi: 10.1093.
    >> Share

  265. UZOKOV J, Alyavi A, Alyavi B, Abdullaev A, et al
    How artificial intelligence can assist with ischaemic heart disease.
    Eur Heart J. 2024;45:1866-1868.
    >> Share

    May 2024
  266. REN J, Bowyer A, Tian DH, Royse C, et al
    Multiple arterial vs. single arterial coronary artery bypass grafting: sex-related differences in outcomes.
    Eur Heart J. 2024 May 31:ehae294. doi: 10.1093.
    >> Share

  267. KELHAM M, Vyas R, Ramaseshan R, Rathod K, et al
    Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: a meta-analysis of invasive vs. conservative management.
    Eur Heart J. 2024 May 28:ehae245. doi: 10.1093.
    >> Share

  268. KWON O, Ahn JH, Koh JS, Park Y, et al
    Platelet-fibrin clot strength and platelet reactivity predicting cardiovascular events after percutaneous coronary interventions.
    Eur Heart J. 2024 May 28:ehae296. doi: 10.1093.
    >> Share

  269. CREA F
    The growing role of coronary computed tomography angiography, polygenic risk scores and electronic nudges in the management of ischaemic heart disease.
    Eur Heart J. 2024;45:1769-1773.
    >> Share

  270. NURMOHAMED NS, van Rosendael AR, Danad I, Ngo-Metzger Q, et al
    Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography.
    Eur Heart J. 2024;45:1783-1800.
    >> Share

  271. HARIK L, Gaudino M
    Coronary angiography and bypass surgery: born together and now going separate ways?
    Eur Heart J. 2024;45:1816-1818.
    >> Share

  272. SERRUYS PW, Kageyama S, Pompilio G, Andreini D, et al
    Coronary bypass surgery guided by computed tomography in a low-risk population.
    Eur Heart J. 2024;45:1804-1815.
    >> Share

  273. LEE YJ, Shin S, Kwon SW, Suh Y, et al
    Ticagrelor monotherapy for acute coronary syndrome: an individual patient data meta-analysis of TICO and T-PASS trials.
    Eur Heart J. 2024 May 16:ehae249. doi: 10.1093.
    >> Share

  274. DVIR D, Tchetche D, Leon MB, Genereux P, et al
    Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study.
    Eur Heart J. 2024 May 15:ehae303. doi: 10.1093.
    >> Share

  275. PAOLUCCI L, Mangiacapra F, Sergio S, Nusca A, et al
    Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis.
    Eur Heart J. 2024 May 14:ehae266. doi: 10.1093.
    >> Share

  276. CREA F
    Focus on ischaemic heart disease: prevention with colchicine, role of the brain-heart axis, new therapeutic targets for ischaemia-reperfusion injury.
    Eur Heart J. 2024;45:1577-1581.
    >> Share

  277. TAKAHARA M, Soga Y, Iida O
    Lower extremity arterial disease vs. coronary artery disease: mortality differences after revascularization.
    Eur Heart J. 2024;45:1634-1643.
    >> Share

  278. AMPONSAH-OFFEH M, Tual-Chalot S, Stellos K
    Repurposing of an antiasthmatic drug may reduce NETosis and myocardial ischaemia/reperfusion injury.
    Eur Heart J. 2024;45:1681-1683.
    >> Share

  279. YANG K, Gao R, Chen H, Hu J, et al
    Myocardial reperfusion injury exacerbation due to ALDH2 deficiency is mediated by neutrophil extracellular traps and prevented by leukotriene C4 inhibition.
    Eur Heart J. 2024;45:1662-1680.
    >> Share

  280. ADLAM D, van Dijk FS, Loeys B
    Genetic testing in patients with unexplained coronary aneurysms or dilation.
    Eur Heart J. 2024;45:1610-1612.
    >> Share

  281. JONES DA, Beirne AM, Kelham M, Wynne L, et al
    Inorganic nitrate benefits contrast-induced nephropathy after coronary angiography for acute coronary syndromes: the NITRATE-CIN trial.
    Eur Heart J. 2024;45:1647-1658.
    >> Share

  282. XIAO Q, Xu Y, Wang S
    Gastropericardial fistula complicated by severe multi-vessel coronary spasm.
    Eur Heart J. 2024;45:1685.
    >> Share

  283. CHEN Z, Dazard JE, Khalifa Y, Motairek I, et al
    Artificial intelligence-based assessment of built environment from Google Street View and coronary artery disease prevalence.
    Eur Heart J. 2024;45:1540-1549.
    >> Share

  284. HEUSCH G, Kleinbongard P
    Cardioprotection research has left its comfort zone.
    Eur Heart J. 2024;45:1568-1570.
    >> Share

  285. VERGALLO R, Patrono C
    Weekly journal scan: intravascular imaging to guide percutaneous coronary intervention-ready for prime time?
    Eur Heart J. 2024 May 4:ehae242. doi: 10.1093.
    >> Share

    April 2024
  286. NGO LTH, Peng Y, Denman R, Yang I, et al
    Long-term outcomes after hospitalization for atrial fibrillation or flutter.
    Eur Heart J. 2024 Apr 28:ehae204. doi: 10.1093.
    >> Share

  287. GALIUTO L, Volpe M
    Weekly journal scan: excess incidence of unexpected health outcomes following myocardial infarction-broader paths for secondary prevention.
    Eur Heart J. 2024 Apr 15:ehae229. doi: 10.1093.
    >> Share

  288. BHATT AS, Johansen ND, Modin D, Claggett BL, et al
    Electronic nudges increase influenza vaccination utilization after myocardial infarction: the nationwide NUDGE-FLU implementation trial.
    Eur Heart J. 2024 Apr 10:ehae235. doi: 10.1093.
    >> Share

  289. VERGALLO R, Galiuto L
    Weekly journal scan: angina severity reduced by percutaneous coronary intervention in the ORBITA-2 trial.
    Eur Heart J. 2024 Apr 10:ehae215. doi: 10.1093.
    >> Share

  290. CREA F
    The complex interaction between cancer, ischaemic heart disease, and heart failure, and a focus on arrhythmias including risk stratification in Brugada syndrome and leadless pacing.
    Eur Heart J. 2024;45:1183-1187.
    >> Share

  291. KASKI JC, Al-Lamee R, Boden WE
    The year in cardiovascular medicine 2023: the top 10 papers in ischaemic heart disease.
    Eur Heart J. 2024;45:1201-1204.
    >> Share

  292. AMERI P, Bertero E, Lombardi M, Porto I, et al
    Ischaemic heart disease in patients with cancer.
    Eur Heart J. 2024;45:1209-1223.
    >> Share

  293. BYRNE R, Coughlan JJ, Rossello X, Ibanez B, et al
    The '10 commandments' for the 2023 ESC Guidelines for the management of acute coronary syndromes.
    Eur Heart J. 2024;45:1193-1195.
    >> Share

  294. CALLEGARI A, Bonnet D, Malekzadeh-Milani S
    Successful percutaneous treatment of perinatal complete left coronary thrombotic occlusion.
    Eur Heart J. 2024;45:1285.
    >> Share

  295. WU VC, Yeh JK, Chen SW, Wu CL, et al
    Syphilis and cardiovascular risk: a Taiwanese registry.
    Eur Heart J. 2024 Apr 3:ehae183. doi: 10.1093.
    >> Share

  296. SAYAH N, Bhatt DL, Miller M, Brinton EA, et al
    Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial.
    Eur Heart J. 2024;45:1173-1176.
    >> Share

    March 2024
  297. LI L, Pang S, Starnecker F, Mueller-Myhsok B, et al
    Integration of a polygenic score into guideline-recommended prediction of cardiovascular disease.
    Eur Heart J. 2024 Mar 29:ehae048. doi: 10.1093.
    >> Share

  298. WYLD M, Webster AC
    Myocardial infarction and stroke in patients with kidney failure: can we do better?
    Eur Heart J. 2024 Mar 27:ehae153. doi: 10.1093.
    >> Share

  299. TSUDA K, Nagamatsu W, Morii I
    A collateral channel from the bronchial artery in chronic total occlusion of proximal right coronary artery.
    Eur Heart J. 2024;45:1087.
    >> Share

  300. VILAHUR G, Radike M, Sutelman P, Ben-Aicha S, et al
    Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective effects in experimental myocardial infarction.
    Eur Heart J. 2024 Mar 15:ehae107. doi: 10.1093.
    >> Share

  301. URSO S, Sadaba R, Dayan V
    Benefits of coronary artery bypass grafting over percutaneous coronary intervention in left main disease: the strength of the evidence.
    Eur Heart J. 2024 Mar 5:ehae135. doi: 10.1093.
    >> Share

  302. VERGALLO R, Galiuto L
    Weekly journal scan: do biodegradable polymer stents provide a durable benefit in patients with ST-segment elevation myocardial infarction?
    Eur Heart J. 2024 Mar 4:ehae119. doi: 10.1093.
    >> Share

  303. GALLACHER PJ, Yeung D, Bell S, Shah ASV, et al
    Kidney replacement therapy: trends in incidence, treatment, and outcomes of myocardial infarction and stroke in a nationwide Scottish study.
    Eur Heart J. 2024 Mar 1:ehae080. doi: 10.1093.
    >> Share

  304. CREA F
    Ischaemic heart disease: prevention, management, mechanisms, and new therapeutic targets.
    Eur Heart J. 2024;45:637-641.
    >> Share

  305. JANSEN TPJ, Wentzel JJ, Damman P
    Interplay between coronary bridging and high shear stress in the emergence of coronary vasospasm.
    Eur Heart J. 2024;45:737.
    >> Share

    February 2024
  306. CHEONG HS, Chang Y, Kim Y, Kwon MJ, et al
    Human papillomavirus infection and cardiovascular mortality: a cohort study.
    Eur Heart J. 2024 Feb 7:ehae020. doi: 10.1093.
    >> Share

  307. THYREGOD HGH, Jorgensen TH, Ihlemann N, Steinbruchel DA, et al
    Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.
    Eur Heart J. 2024 Feb 7:ehae043. doi: 10.1093.
    >> Share

    January 2024
  308. SENIOR R, Khattar RS
    To test or not to test for ischaemia routinely after percutaneous coronary intervention in diabetic patients: is the jury still out?
    Eur Heart J. 2024 Jan 30:ehad877. doi: 10.1093.
    >> Share

  309. PERSITS I, Layoun H, Kondoleon NP, Spilias N, et al
    Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement.
    Eur Heart J. 2024 Jan 25:ehae019. doi: 10.1093.
    >> Share

  310. GOBEIL E, Bourgault J, Mitchell PL, Houessou U, et al
    Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic risk.
    Eur Heart J. 2024 Jan 19:ehad845. doi: 10.1093.
    >> Share

  311. LI Z, Zhang H, Lin S
    Functionally bicuspid aortic valve leads to myocardial ischaemia.
    Eur Heart J. 2024 Jan 18:ehad891. doi: 10.1093.
    >> Share

    December 2023
  312. PIRIOU PG, Plessis J, Guerin P
    Transcatheter aortic valve replacement in patients with cardiogenic shock: safe and effective, but the most critical patients require further investigations.
    Eur Heart J. 2023 Dec 14:ehad808. doi: 10.1093.
    >> Share

    November 2023
  313. LU ZN, Yang Y, Song G
    A patient-tailored clipping strategy of transcatheter edge-to-edge repair as salvage for cardiogenic shock complicated by mitral valve cleft and bileaflet flails.
    Eur Heart J. 2023 Nov 29:ehad802. doi: 10.1093.
    >> Share

  314. HENRY CM, Oseran AS, Zheng Z, Dong H, et al
    Cardiovascular Hospitalizations and Mortality Among Adults Aged 25 to 64 years in the United States.
    Eur Heart J. 2023 Nov 11:ehad772. doi: 10.1093.
    >> Share

  315. KIM H, Kang DY, Lee J, Choi Y, et al
    Routine stress testing in diabetic patients after percutaneous coronary intervention: the POST-PCI trial.
    Eur Heart J. 2023 Nov 2:ehad722. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016